Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details


Education & Training

  • Fellowship Program, Allergy/Immunology, 2013
    Children's Hospital of Philadelphia
  • Residency Program, Pediatrics, 2010
    Johns Hopkins Hospital
  • Internship Program, Pediatrics, 2008
    Johns Hopkins Hospital
  • MD, 2007
    Duke University School of Medicine
  • BS, 2002
    University of Virginia

Board Certifications

  • American Board of Allergy and Immunology
  • American Board of Pediatrics

National Provider ID: 1174724405


Michael Keller, M.D., is a pediatric immunologist at Children's National Health System. He is a specialist in the diagnosis and treatment of primary and secondary disorders of immunity. He is board-certified in allergy and immunology, as well as pediatrics, and is a member of the American Academy of Allergy, Asthma, and Immunology; the Clinical Immunology Society; and the European Society of Immunodeficiency. He is also an active member of the Primary Immunodeficiency Treatment Consortium (PIDTC).

Dr. Keller has authored many peer-reviewed articles and abstracts and is a member of the AAAAI/ACAAI practice parameter committee for Treatment and Diagnosis of Primary Immunodeficiency Disorders. His specialties include disorders of immunity and care of immunologically vulnerable patients. 

Dr. Keller's research interests focus on the use of antiviral T-cell therapies in bone marrow transplantation, including expanding the use of this therapy to benefit children with primary immunodeficiency disorders. He is associated with the Center for Emerging Technologies in Immune cell therapies, under Dr. Catherine Bollard.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • HZNP USA Inc. 

Immunologic special forces: Anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation

(2014) Journal of ImmunoTargets and Therapy

Burden of copy number variation in Common Variable Immunodeficiency

(2014) Clinical & Experimental Immunology

Incidence of Immunodeficiency in 49, XXXXY chromosomal variation

(2013) American Journal of Medical Genetics Part C

Severe combined immunodeficiency resulting from mutations in MTHFD1

(2013) Pediatrics

Chipping away at a mountain: Genomic studies in Common Variable Immunodeficiency

(2012) Autoimmunity Reviews